Randomized, Double-Blind, Single-Dose, Efficacy and Safety Study of Test Acetaminophen Tablet in Postoperative Dental Pain
Status:
Completed
Trial end date:
2018-04-12
Target enrollment:
Participant gender:
Summary
To evaluate analgesic onset, efficacy, and safety of 1000 mg acetaminophen administered as
two Test Acetaminophen 500 mg tablets (Test ACM) compared with 1000 mg acetaminophen
administered as two commercial acetaminophen 500 mg caplets (ACM) and 400 mg ibuprofen
administered as two commercial ibuprofen 200 mg liquid-filled capsules (IBU) in the dental
pain model following third-molar extractions.
Phase:
Phase 3
Details
Lead Sponsor:
Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division
Collaborator:
Johnson & Johnson Consumer and Personal Products Worldwide